Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin
about
Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attackPeroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in patients with stroke or transient ischaemic attackAntithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementiaCost-Effectiveness of Dabigatran Compared to Vitamin-K Antagonists for the Treatment of Deep Venous Thrombosis in the Netherlands Using Real-World DataSecondary prophylactic treatment and long-term prognosis after TIA and different subtypes of stroke. A 25-year follow-up hospital-based observational study.Peroxisome proliferator-activated receptor gamma agonists for preventing recurrent stroke and other vascular events in people with stroke or transient ischaemic attack.Antiplatelet Therapy for Secondary Prevention of Vascular Disease Complications.Serious hemorrhages after ischemic stroke or TIA - Incidence, mortality, and predictors.
P2860
Q24186319-B0CEF5CA-7F76-475D-8C9A-F63EC8554B08Q24201174-C82B25D3-410C-44DF-8BC9-F7108F758587Q26471267-FCD66A9C-594E-4F63-A2C9-3865D2E8204EQ30985137-A632638A-0DB8-486C-B526-FE5442022C49Q37599670-A4083A4B-E426-4DAE-A552-44B536EBE411Q47380989-70D73787-1531-4CF6-ADEB-BE6920E16D13Q47657861-56952FD0-55E1-46FF-8DCB-59241303FF6DQ55279655-9F3CF122-F977-49DB-ABB9-B75AA6EFAA11
P2860
Vitamin K antagonists versus antiplatelet therapy after transient ischaemic attack or minor ischaemic stroke of presumed arterial origin
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@ast
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@en
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@en-gb
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@nl
type
label
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@ast
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@en
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@en-gb
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@nl
prefLabel
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@ast
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@en
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@en-gb
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@nl
P2093
P2860
P1476
Vitamin K antagonists versus a ...... ke of presumed arterial origin
@en
P2093
Els LLM De Schryver
Jan van Gijn
L Jaap Kappelle
Peter J Koudstaal
P2860
P356
10.1002/14651858.CD001342.PUB3
P50
P577
2012-09-12T00:00:00Z